Recall Weekly
Moderate riskFDA DrugClass II

Teva metoprolol succinate tablets recalled for failed dissolution

Teva Pharmaceuticals is recalling specific lots of Metoprolol Succinate Extended-Release 25 mg tablets because they failed to meet dissolution specifications—meaning the tablets may not break down and release the medication properly in your body. This could result in the drug not working as intended. No injuries have been reported.

From the FDA notice · Read the official notice ↗ · All Teva recalls

What to do

  1. Check if your metoprolol bottles match the recalled lot numbers and expiration dates listed in the recall notice
  2. Contact your pharmacy or doctor if you have one of the affected bottles
  3. Do not stop taking metoprolol without talking to your doctor first—this is a heart medication
  4. Your pharmacist can provide a replacement or alternative medication
Official notice ↗

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Metoprolol Succinate Extended-Release Tablets, 25 mg, 100 tablets bottles (NDC: 45963-709-11) and 1,000 tablets bottles (NDC: 45963-709-96), Rx Only, Teva Pharmaceuticals, Parsippany, NJ 07054
Sold in
Nationwide
Made for
Adults (0 months and older)

This recall covers 4 products — see all of them.

Details

Units affected
18,780 bottles
Illnesses reported
None reported
Manufactured in
400 Interpace Pkwy Bldg A, N/A, Parsippany, NJ, United States
Classification
Class II
Recall number
D-0354-2026

In the FDA's words

Description
Metoprolol Succinate Extended-Release Tablets, 25 mg, 100 tablets bottles (NDC: 45963-709-11) and 1,000 tablets bottles (NDC: 45963-709-96), Rx Only, Teva Pharmaceuticals, Parsippany, NJ 07054 Failed Dissolution Specifications Lot#: a) 0715J251, Exp.: 12/2026; 0716J251, Exp.: 01/2027; 0717J251, Exp.: 01/2027; b) 0715J252, Exp.: 12/2026; 0716J252, Exp.: 01/2027, 0717J252, Exp.: 01/2027. Distribution: Nationwide Affected quantity: 18,780 bottles
Hazard
Failed Dissolution Specifications

4 products in this recall

Teva metoprolol succinate tablets recalled for dissolution failure

Teva is recalling four strengths of metoprolol succinate extended-release tablets (25 mg, 50 mg, 100 mg and 200 mg), sold in 100- and 1,000-tablet bottles. The tablets did not meet the required dissolution specification, which means they may not release the medicine at the expected rate. No injuries have been reported.

The agency lists each product separately. Check every one you might have.

More from Teva

See all

Related topics

PotencyDrugsSold nationwideMore from FDA Drug